{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T08:52:20Z","timestamp":1793436740360,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.fertnstert.2021.02.030","type":"journal-article","created":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T19:46:09Z","timestamp":1617479169000},"page":"538-545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Fertility treatments and breast cancer risk in Jewish Israeli BRCA mutation carriers"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4042-6554","authenticated-orcid":false,"given":"Tamar","family":"Perri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shani","family":"Naor-Revel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry","family":"Eliassi-Revivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dror","family":"Lifshitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitan","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Korach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2021.02.030_bib1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib2","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib3","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018315","article-title":"Reproductive and lifestyle factors related to breast cancer among Japanese women: an observational cohort study","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ctrv.2016.07.006","article-title":"Reproductive behaviors and risk of developing breast cancer according to tumor subtype: a systematic review and meta-analysis of epidemiological studies","volume":"49","author":"Lambertini","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10549-015-3328-0","article-title":"Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies","volume":"150","author":"Gennari","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jama.2016.9389","article-title":"Ovarian stimulation for in\u00a0vitro fertilization and long-term risk of breast cancer","volume":"316","author":"van den Belt-Dusebout","year":"2016","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/humupd\/dmt034","article-title":"IVF and breast cancer: a systematic review and meta-analysis","volume":"20","author":"Sergentanis","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/GCO.0000000000000370","article-title":"Use of fertility medications and cancer risk: a review and update","volume":"29","author":"Kroener","year":"2017","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib9","first-page":"1111","article-title":"Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study","volume":"19","author":"Kotsopoulos","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41416-018-0139-1","article-title":"Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1\/2 mutation carriers","volume":"119","author":"Derks-Smeets","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00404-020-05690-4","article-title":"Use of fertility treatments in BRCA1\/2 mutation carriers and risk for ovarian and breast cancer: a systematic review","volume":"302","author":"Huber","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10549-010-1217-0","article-title":"Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel","volume":"127","author":"Laitman","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ygyno.2005.05.002","article-title":"Society of Gynecologic Oncologists Clinical Practice Committee statement on prophylactic salpingo-oophorectomy","volume":"98","author":"Kauff","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib14","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/cncr.29321","article-title":"Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer","volume":"121","author":"Walker","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2009.24.2057","article-title":"Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast\/ovarian cancer risks","volume":"28","author":"Oktay","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib16","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.fertnstert.2014.08.014","article-title":"BRCA1 germline mutations may be associated with reduced ovarian reserve","volume":"102","author":"Wang","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib17","doi-asserted-by":"crossref","first-page":"15931","DOI":"10.18632\/oncotarget.24638","article-title":"Premature ovarian aging in BRCA carriers: a prototype of systemic precocious aging?","volume":"9","author":"Ben-Aharon","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib18","first-page":"588","article-title":"Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners","volume":"32","author":"Gietel-Habets","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib19","doi-asserted-by":"crossref","first-page":"9144","DOI":"10.18632\/oncotarget.13423","article-title":"The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation","volume":"8","author":"Toss","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib20","doi-asserted-by":"crossref","first-page":"102110","DOI":"10.18632\/oncotarget.22193","article-title":"Reproductive factors as risk modifiers of breast cancer in BRCA mutation carriers and high-risk non-carriers","volume":"8","author":"Park","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib21","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1158\/1055-9965.EPI-09-0024","article-title":"Oral contraceptive use and BRCA penetrance: a case-only study","volume":"18","author":"Pasanisi","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib22","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.ejca.2005.03.035","article-title":"Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing","volume":"41","author":"Jernstr\u00f6m","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib23","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1186\/1471-2407-13-584","article-title":"Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study","volume":"13","author":"Ritte","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib24","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.ejca.2010.04.018","article-title":"Oral contraceptive use and breast or ovarian cancer risk in BRCA1\/2 carriers: a meta-analysis","volume":"46","author":"Iodice","year":"2010","journal-title":"Eur J Cancer"},{"issue":"Suppl 3","key":"10.1016\/j.fertnstert.2021.02.030_bib25","first-page":"S167","article-title":"Contraception and breast cancer","volume":"87","author":"Bhothisuwan","year":"2004","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib26","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1586\/era.11.38","article-title":"Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis","volume":"11","author":"Cibula","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib27","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1200\/JCO.2013.48.9021","article-title":"Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis","volume":"31","author":"Moorman","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/gcc.22217","article-title":"Impact of a paternal origin of germline BRCA1\/2 mutations on the age at breast and ovarian cancer diagnosis in a Southern Swedish cohort","volume":"54","author":"Ellberg","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/cge.12037","article-title":"Parental origin of mutation and the risk of breast cancer in a prospective study of women with a BRCA1 or BRCA2 mutation","volume":"84","author":"Senst","year":"2013","journal-title":"Clin Genet"},{"key":"10.1016\/j.fertnstert.2021.02.030_bib30","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1158\/1055-9965.EPI-16-0182","article-title":"Bias explains most of the parent-of-origin effect on breast cancer risk in BRCA1\/2 mutation carriers","volume":"25","author":"Vos","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028221001485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028221001485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:31:09Z","timestamp":1758011469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028221001485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0015028221001485"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2021.02.030","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fertility treatments and breast cancer risk in Jewish Israeli BRCA mutation carriers","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2021.02.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92021 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}